Pharma Journalist - Page 870 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

PharmaMar signs licensing agreement with Eczacıbasi Group for Aplidin

Ammonett Pharma Receives Notice of Allowance of U.S. Patent for “Detecting and treating GHD”

Akebia Therapeutics appoints Rita Jain as SVP and CMO

TrialScope Launches Second Global Clinical Trial Disclosure Maturity

miRagen Therapeutics’s MRG- 106 receives EU Orphan Medicinal Product Designation

Sun Pharma announces that US FDA Filing acceptance of BLA for Tildrakizumab

KBI Biopharma Invests $30M for Expansion projects of Durham and Boulder sites

Selexis SA and OSE Immunotherapeutics signs agreement for development of OSE’s interleukin receptor 7 antagonist

Pierre Fabre acquires Igenica Biotherapeutics Immuno-Oncology

LSNE Contract Manufacturing and Selecta Biosciences signs manufacturing supply agreement